Avoiding pitfalls: what an endoscopist should know in liver transplantation--part II.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 19085103)

Published in Dig Dis Sci on December 17, 2008

Authors

Sharad Sharma1, Ahmet Gurakar, Cemalettin Camci, Nicolas Jabbour

Author Affiliations

1: Nazih Zuhdi Transplant Institute, 3300 North West Expressway, Oklahoma City, OK 73112, USA. drsharadsharma@yahoo.com

Articles cited by this

(truncated to the top 100)

Clostridium difficile colitis. N Engl J Med (1994) 9.31

Clinical practice. Antibiotic-associated diarrhea. N Engl J Med (2002) 7.13

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med (1989) 6.66

Skin cancers after organ transplantation. N Engl J Med (2003) 6.65

Infection in organ-transplant recipients. N Engl J Med (1998) 6.49

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation (2006) 5.33

A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol (2005) 5.26

Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg (2002) 4.91

Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol (1995) 4.39

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med (1996) 3.61

Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol (2002) 3.30

Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis. Lancet (1983) 3.24

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis (2005) 3.01

Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98

Treatment of Clostridium difficile-associated disease: old therapies and new strategies. Lancet Infect Dis (2005) 2.68

A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease. Am J Gastroenterol (1997) 2.65

Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer (2003) 2.64

Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions. J Clin Microbiol (1982) 2.52

SpyGlass single-operator peroral cholangiopancreatoscopy system for the diagnosis and therapy of bile-duct disorders: a clinical feasibility study (with video). Gastrointest Endosc (2007) 2.47

The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg (1994) 2.32

Clostridium difficile: clinical considerations. Rev Infect Dis (1990) 2.28

Increased cancer risk after liver transplantation: a population-based study. J Hepatol (2001) 2.25

The dynamics of human cytomegalovirus replication in vivo. J Exp Med (1999) 2.19

Kaposi's sarcoma after renal transplantation. Nephrol Dial Transplant (1998) 2.14

Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg (1987) 2.11

Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol (1997) 2.05

Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut (1990) 1.99

Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol (2002) 1.94

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected]. Lancet (1997) 1.94

Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood (1994) 1.90

Gastrointestinal Kaposi's sarcoma in patients with acquired immunodeficiency syndrome. Endoscopic and autopsy findings. Gastroenterology (1985) 1.90

Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl (2004) 1.88

Esophageal infections: risk factors, presentation, diagnosis, and treatment. Gastroenterology (1994) 1.86

Biliary strictures following liver transplantation: past, present and preventive strategies. Liver Transpl (2008) 1.81

Biliary complications after duct-to-duct biliary reconstruction in living-donor liver transplantation: causes and treatment. World J Surg (2007) 1.73

Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut (2001) 1.71

Diarrhea in liver transplant recipients: etiology and management. Liver Transpl (2005) 1.71

Helicobacter pylori infection correlates with severity of reflux esophagitis: with manometry findings. J Gastroenterol (1999) 1.71

Infections in liver transplant recipients. Clin Infect Dis (1995) 1.71

Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy. Gastrointest Endosc (2002) 1.70

Delayed wound healing with sirolimus after liver transplant. Ann Pharmacother (2002) 1.69

Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol (2004) 1.67

Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology (1993) 1.67

Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut (1998) 1.63

Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation (2005) 1.62

Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile. Gut (1986) 1.61

Long-term outcome of endoscopic treatment of biliary strictures after liver transplantation. Liver Transpl (2006) 1.60

Severe Clostridium difficile colitis. Dis Colon Rectum (1995) 1.59

Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression. J Virol (1988) 1.57

Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med (1990) 1.57

Cancers complicating organ transplantation. N Engl J Med (1990) 1.57

The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr Probl Surg (1988) 1.56

Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol (2000) 1.56

Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant (1992) 1.54

Use of short tandem repeats for DNA fingerprinting to rapidly diagnose graft-versus-host disease in solid organ transplant patients. Transplantation (2006) 1.54

Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. Transplantation (2001) 1.53

"Will all liver transplantation patients eventually die from cancer?". J Hepatol (2005) 1.52

Malignancy in renal transplantation. J Am Soc Nephrol (2004) 1.50

Biliary complications and outcomes of liver transplantation from donors after cardiac death. Liver Transpl (2007) 1.50

The involvement of the gastrointestinal tract in posttransplant lymphoproliferative disease in pediatric liver transplantation. J Pediatr Gastroenterol Nutr (1999) 1.43

Liver transplant-associated graft-versus-host disease. Transplantation (2003) 1.43

Venous complications after orthotopic liver transplantation. Clin Transplant (2000) 1.43

Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. Am J Med (1989) 1.41

Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis (1995) 1.39

Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood (2001) 1.38

Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease. Transplantation (1998) 1.33

Biliary strictures in 130 consecutive right lobe living donor liver transplant recipients: results of a Western center. Am J Transplant (2007) 1.30

Myeloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: characteristics, risk factors and prognosis. Transplantation (2006) 1.29

Viral infection in the renal transplant recipient. J Am Soc Nephrol (2005) 1.29

Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease. J Infect Dis (2002) 1.28

Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation (1998) 1.28

Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease. Am J Transplant (2006) 1.26

Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation? Ann Surg (2003) 1.26

Inflammatory bowel disease: new insights into pathogenesis and treatment. J Intern Med (2002) 1.23

Safety of duct-to-duct biliary reconstruction in right-lobe live-donor liver transplantation without biliary drainage. Transplantation (2004) 1.23

Antibiotic associated pseudomembranous colitis with negative proctosigmoidoscopy examination. Gastroenterology (1979) 1.22

The problem of cancer in organ transplant recipients: an overview. Transplant Sci (1994) 1.22

Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease. Transpl Infect Dis (2001) 1.22

Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology (2002) 1.21

Fungal infections in solid organ transplant recipients. Infect Dis Clin North Am (1995) 1.20

Kaposi's sarcoma of internal organs. A multiparameter study of 86 cases. Cancer (1995) 1.20

Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response. Blood (2000) 1.20

Portal vein thrombosis: a concise review. Am J Gastroenterol (2002) 1.20

Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin North Am (2003) 1.19

Cytomegalovirus infection in patients with inflammatory bowel disease. Am J Gastroenterol (1999) 1.19

Cytomegalovirus infection following liver transplantation: review of the literature. Clin Infect Dis (1996) 1.19

Endoscopic treatment of biliary complications after right-lobe living-donor liver transplantation with duct-to-duct biliary anastomosis. J Hepatobiliary Pancreat Surg (2006) 1.17

Nosocomial fungal infections: candidemia. Diagn Microbiol Infect Dis (1999) 1.16

Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg (2002) 1.16

Esophageal and gastric Kaposi's sarcomas presenting as upper gastrointestinal bleeding. Chang Gung Med J (2002) 1.16

Clinical course and management of inflammatory bowel disease after liver transplantation. Transplantation (1998) 1.15

Acute graft versus host disease following liver transplantation: the enemy within. Am J Transplant (2004) 1.14

Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation (2003) 1.14

Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment. Dis Colon Rectum (2003) 1.14

Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study. Dis Colon Rectum (1997) 1.13

Biliary anastomotic complications in 400 living related liver transplantations. World J Surg (2001) 1.13

Portal vein thrombosis. Hepatobiliary Pancreat Dis Int (2005) 1.12

Articles by these authors

The possible contribution of 129I in the drinking water and food supply to the nodular formation of thyroid tissue. Health Phys (2005) 2.01

Biliary strictures following liver transplantation: past, present and preventive strategies. Liver Transpl (2008) 1.81

Predictive value of procalcitonin for the diagnosis of bowel strangulation. World J Surg (2005) 1.51

Pneumatosis cystoides intestinalis: a single center experience. World J Gastroenterol (2012) 1.32

Pilonidal sinus treated with crystallized phenol: an eight-year experience. Dis Colon Rectum (2004) 1.19

Extended pancreatectomy with resection of the celiac axis: the modified Appleby operation. Am J Surg (2006) 1.12

Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes. Ann Surg Oncol (2012) 1.11

Ciliated hepatic foregut cyst: an increasingly diagnosed condition. Hepatobiliary Pancreat Dis Int (2008) 1.04

Foregut cystic developmental malformation: new taxonomy and classification--unifying embryopathological concepts. Indian J Pathol Microbiol (2009) 1.04

Improved prediction of outcome in patients with severe acute pancreatitis by the APACHE II score at 48 hours after hospital admission compared with the APACHE II score at admission. Acute Physiology and Chronic Health Evaluation. Arch Surg (2002) 1.00

Epidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter study. Jpn J Clin Oncol (2008) 0.97

The faltering solid organ donor pool in the United States (2001-2010). World J Surg (2012) 0.95

Management of hepatic metastasis from colorectal cancers: an update. J Hepatobiliary Pancreat Surg (2008) 0.95

Unusual cases of jaundice secondary to non-neoplastic bile duct obstruction. Am Surg (2004) 0.93

Continuous cerebral blood flow autoregulation monitoring in patients undergoing liver transplantation. Neurocrit Care (2012) 0.92

Hepatitis C virus and its renal manifestations: a review and update. Gastroenterol Hepatol (N Y) (2012) 0.92

Cadmium exposure and liver disease among US adults. J Gastrointest Surg (2013) 0.92

Comparison of Kugel and Lichtenstein operations for inguinal hernia repair: results of a prospective randomized study. World J Surg (2006) 0.90

Three-year Results of a Pilot Program in Early Liver Transplantation for Severe Alcoholic Hepatitis. Ann Surg (2017) 0.90

Orthotopic liver transplant using allografts from geriatric population in the United States: is there any age limit? Exp Clin Transplant (2010) 0.90

Delayed and unsuccessful endoscopic retrograde cholangiopancreatography are associated with worse outcomes in patients with acute cholangitis. Clin Gastroenterol Hepatol (2012) 0.90

Crystallized phenol in nonoperative treatment of previously operated, recurrent pilonidal disease. Dis Colon Rectum (2010) 0.89

Anemia and transfusions in patients undergoing surgery for cancer. Ann Surg Oncol (2007) 0.89

Ciliated hepatic foregut cyst: an increasingly diagnosed condition. Dig Dis Sci (2008) 0.88

Centre volume and resource consumption in liver transplantation. HPB (Oxford) (2012) 0.87

Multiplex cytokine profiling of initial therapeutic response in patients with chronic hepatitis C virus infection. Dig Dis Sci (2005) 0.86

Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis. Digestion (2014) 0.85

Management of biliary stricture guided by the Spyglass Direct Visualization System in a liver transplant recipient: an innovative approach. Gastrointest Endosc (2008) 0.85

Management of large hepatocellular carcinoma in adult patients with Alagille syndrome: a case report and review of literature. Dig Dis Sci (2010) 0.84

Liver transplant patients have a risk of progression similar to that of sporadic patients with branch duct intraductal papillary mucinous neoplasms. Liver Transpl (2014) 0.83

Is left lobe adult-to-adult living donor liver transplantation ready for widespread use? The US experience (1998-2010). HPB (Oxford) (2012) 0.83

Sirolimus based immunosuppression is associated with need for early repeat therapeutic ERCP in liver transplant patients with anastomotic biliary stricture. Ann Hepatol (2013) 0.82

Gallbladder mass with a carbohydrate antigen 19-9 level in the thousands: malignant or benign pathology? Report of a case. Surg Today (2007) 0.82

Comparison of outcomes in noncomplicated and in higher-risk donors after standard versus hand-assisted laparoscopic nephrectomy. Am Surg (2003) 0.81

Characteristics and management of splenic artery aneurysm in liver transplant candidates and recipients. Am Surg (2003) 0.81

Surgical clips: a nidus for foreign body reaction after hepatic resection. Surg Laparosc Endosc Percutan Tech (2005) 0.81

The application of SpyScope® technology in evaluation of pre and post liver transplant biliary problems. Turk J Gastroenterol (2010) 0.80

Left extended hepatectomy for a metastatic gastrointestinal stromal tumor after a disease-free interval of 17 years: report of a case. Surg Today (2007) 0.79

Minimally invasive resection of choledochal cyst: a feasible and safe surgical option. J Gastrointest Surg (2014) 0.79

Outcomes in partial liver transplantation: deceased donor split-liver vs. live donor liver transplantation. HPB (Oxford) (2011) 0.79

Patterns of consultation and treatment of patients with hepatocellular carcinoma presenting to a large academic medical center in the US. J Gastrointest Surg (2013) 0.79

Sirolimus may be associated with early recurrence of biliary obstruction in liver transplant patients undergoing endoscopic stenting of biliary strictures. Ann Hepatol (2011) 0.79

Portopulmonary Hypertension and Liver Transplant: Recent Review of the Literature. Exp Clin Transplant (2016) 0.78

Pancreaticoduodenectomy in adults with congenital intestinal rotation disorders. Pancreas (2005) 0.78

The efficiency of various doses of topical isosorbide dinitrate in the treatment of chronic anal fissure and the long-term results: a prospective, randomized and controlled clinical trial. Turk J Gastroenterol (2012) 0.78

Donor-transmitted malignancy in a liver transplant recipient: a case report and review of literature. Dig Dis Sci (2012) 0.77

Rare cause of delayed upper gastrointestinal bleeding after pancreaticoduodenectomy. JOP (2012) 0.77

Nutritional effects of transjugular intrahepatic portosystemic shunt--an often neglected benefit? "A preliminary report". J Okla State Med Assoc (2009) 0.77

Restricting fresh frozen plasma in hepatic resections. J Am Coll Surg (2003) 0.77

Implications of Treating Hepatitis C Virus Infection Among Patients Awaiting Cadaveric Liver Transplant: A Single-Center Experience. Exp Clin Transplant (2015) 0.77

Clinical decision-making by gastroenterologists and hepatologists for patients with early hepatocellular carcinoma. Ann Surg Oncol (2014) 0.76

Recent advances in liver transplantation for the practicing gastroenterologist. Gastroenterol Hepatol (N Y) (2009) 0.76

HTK preservative solution is associated with increased biliary complications among patients receiving DCD liver transplants: a single center experience. Ann Transplant (2013) 0.76

Does the site of platelet sequestration predict the response to splenectomy in adult patients with immune thrombocytopenic purpura? Platelets (2014) 0.76

The effect of antivascular endothelial growth factor on the development of adhesion formation in laparotomized rats: experimental study. Gastroenterol Res Pract (2011) 0.75

Acute liver failure: a management challenge for the practicing gastroenterologist. Gastroenterol Hepatol (N Y) (2010) 0.75

Optimal cytoreduction after combined resection and radiofrequency ablation of hepatic metastases from recurrent malignant ovarian tumors. Gynecol Oncol (2005) 0.75

Hepatitis C following liver transplantation: current approach and future research opportunities. Curr Opin Infect Dis (2016) 0.75

Role of coronary artery calcium score in identifying occult coronary artery disease in patients evaluated for deceased-donor liver transplant - a preliminary report. Exp Clin Transplant (2015) 0.75

Prophylaxis Among Hepatitis B Core Antibody-positive Deceased-donor Liver Transplant Recipients: Hepatitis B Immunoglobulin Plus Oral Antiviral Agents Versus Antiviral Agents Alone: A Single-center Experience. Exp Clin Transplant (2016) 0.75

Unusual presentation of recurrent hepatocellular carcinoma as obstructive jaundice 15 years after liver transplant. Exp Clin Transplant (2007) 0.75

Compatible ABO mismatch and liver transplantation: a single center's experience. Exp Clin Transplant (2006) 0.75

Hepatocellular carcinoma: status in the era of liver transplantation. J Okla State Med Assoc (2009) 0.75

Gastroduodenal artery pseudoaneurysm secondary to pancreatic head biopsy. J Ultrasound Med (2004) 0.75

Management of an abdominal aortic aneurysm in a patient with end-stage liver disease. Am J Transplant (2004) 0.75

Microvascular Invasion in Hepatocellular Carcinoma and Liver Transplant. Exp Clin Transplant (2016) 0.75

[Skin defect coverage with micro skin graft]. Ulus Travma Derg (2002) 0.75

Predictive Modeling of Massive Transfusion Requirements During Liver Transplantation and Its Potential to Reduce Utilization of Blood Bank Resources. Anesth Analg (2017) 0.75

Diagnosing hepatitis C virus and improved outcomes in overall and kidney graft survival among simultaneous liver-kidney transplant recipients in the post-MELD era. Exp Clin Transplant (2014) 0.75

Inhibitory effects of sildenafil citrate on the tonus of isolated dog internal anal sphincter. Dis Colon Rectum (2005) 0.75

Pre- Versus Posttransplant Treatment of Hepatitis C Virus With Direct-Acting Antivirals in Liver Transplant Recipients: More Issues to be Solved. Exp Clin Transplant (2017) 0.75

Marked reduction of the alpha-fetoprotein levels among individuals with chronic hepatitis C, following PEG-interferon and ribavirin treatment. J Clin Gastroenterol (2005) 0.75

Successful transplantation of donation-after-cardiac-death liver in recipient with MELD score of 40. Transplantation (2006) 0.75

Living related donor nephrectomy in transfusion refusing donors. Transpl Int (2007) 0.75

Avoiding pitfalls: what an endoscopist should know in liver transplantation--part 1. Dig Dis Sci (2007) 0.75